Feeling for my fellow Canadian/International colleagues in medicine and science who aspire to be new H1B visa holders to train in the U.S. Hopefully the full clarification of the rules (and exemptions) will come soon.

We are proud to present a Special Issue on Cancer Neuroscience, curated by editors Bennie Babayan & Ted Dobie. This issue offers a snapshot of the field through a collection of Perspectives, Reviews, and NeuroViews: https://t.co/k9qAOtuIxB. See below for details on the pieces:

It’s been an honor and privilege to be involved with Dr. Mukkamala’s care.

When Dr. Bobby Mukkamala learned he had a brain tumor, he relied on the cutting-edge surgical techniques at Mayo Clinic to get him back to his professional work. Read his story: https://t.co/UyrutSbu91

A big congratulations to @HerveyJumper on being elected President-Elect of @NeuroOnc! 🎉 He will be the sixth neurosurgeon and fourth @UCSF physician to serve in this role. #UCSFProud @UCSFCancer @UCSFHospitals

Congratulations to @HerveyJumper for being named this year's recipient of the Abhijit Guha Award from @NSTumorSection and @NeuroOnc! 🎉 This award recognizes his accomplishments as a neurosurgeon-scientist and his role as a mentor in the field of neuro-oncology. #SNO2025

Join us in congratulating the 2025 graduates of the @MayoClinic Department of Neurosurgery! Fellows: Dr. Michael Keough Dr. Ken Porche Dr. David Peters Residents: Dr. Patrick Flanigan Dr. Ryan Naylor Wishing them all the best in the next chapter!

The pioneer of cancer neuroscience, @michelle_monje, w/ Frank Winkler @BrainPrize, profiled @TheLancet today @Stanford @StanfordMed @KarlDeisseroth https://t.co/8C5bJYKo1N

🚀 Xaira Therapeutics has just dropped a game-changer for AI-driven biology. Today, we unveiled X-Atlas/Orion, the largest publicly available genome-wide Perturb-seq dataset to date—spanning 8.4 million single cells with perturbations across all ~20,000 human protein-coding

Last evening we celebrated the graduating residents and fellows from @MayoClinicNeuro. It was an honor to train with @IanParneyMDPhD and @TerryBurnsLab in Neurosurgical Oncology!

After 31 years of service, Dr. John Atkinson was celebrated by the #Neurosurgery team at @MayoClinic as he prepares for retirement. His final day in the OR marked the close of a historic career—filled with dedication, mentorship, and excellence.

Celebrating John Atkinson ⁦@MayoClinicNeuro⁩

as we bid goodbye to the legendary Prof.Gazi Yasargil, let's relive a moment with him https://t.co/PWvn9lYK5Q

Congrats @StephenBagleyMD @DrORourke2 and colleagues @PennCancer on their manuscript in @NatureMedicine showing safety and early efficacy of bivalent CAR T cells in 18 patients with recurrent #glioblastoma! https://t.co/n2QewBy7MZ

The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial @NEJM #ASCO25 https://t.co/rJXBq11wmC

This evening in Copenhagen, H.M. The King presented The Brain Prize to Professors Frank Winkler and @Michelle_Monje at the prestigious annual ceremony. Our heartfelt congratulations - an extraordinary recognition of pioneering contributions to #research into cancer neuroscience.

It’s game time! The #Neurosurgery softball team, Skull Crushers, are hitting the fields on Thursday nights at the McQuillan Field Park, in Rochester and are sure to stitch up some victories this summer! Their next game is May 29 on field 4 at 8:15pm.

Harvard notified me today that this K99 grant is terminated.

CAR T cell therapy can be life-saving, but like many other cancer therapies, can cause long-term “brain fog”. We discovered the cellular dysregulation underpinning this and a strategy to rescue the cellular and cognitive dysfunction in mice.

Beautiful spring morning run around Silver Lake in Rochester, Minnesota. Greeted by some fellow Canadian honkers!